Written Question·Department of Health and Social Care·UIN HL5291

Tabled: 12 November 2026

Question

To ask His Majesty's Government what assessment they have made of the progress the National Institute for Health and Care Excellent have made towards licensing Omaveloxolone for use in the NHS to treat Friedreich’s Ataxia.